Back to search
FDAFDA · Food and drugs·Recall number D-003-2013

Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.

Published October 10, 2012 · Recall initiated: August 21, 2012

Summary

FDA records drug Class II recall D-003-2013, published October 10, 2012 and initiated August 21, 2012. Recalling firm: Caraco Pharmaceutical Laboratories Ltd.; Status: Terminated; Reported quantity: a) 2424 Cartons b) 2675 Cartons; Lot: Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Crystallization: Presence of crystals of Nimodipine within the capsule solution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Caraco Pharmaceutical Laboratories Ltd.
Distributor
One direct account - Caraco Pharmaceutical Labroatories, LTD Detroit, Michigan 78 sub accounts
Lot
Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc. recalled?

Yes. FDA published recall D-003-2013 on October 10, 2012. Reported hazard: Crystallization: Presence of crystals of Nimodipine within the capsule solution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter